Avita Medical Ltd.

Back to All Transactions

Avita Medical Ltd.
For more information regarding this transaction contact:
  • Dave McDonald Investment Banking 612.326.1268
  • Rob Martin Investment Banking 612.260.5850

Lake Street is pleased to announce it served as lead placement agent for Avita Medical Ltd. (ASX:AVH), (OTCQX:AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, in its offering of 107,727,359 common shares at AUD$0.093 per common share. Gross proceeds were approximately AUD$10,018,644.

About Avita Medical

Avita Medical develops and distributes regenerative products for the treatment of a broad range of wounds, scars and skin defects. Avita's patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient's own skin. The Company's lead product, ReCell®, is used in the treatment of a wide variety of burns, plastic, reconstructive and cosmetic procedures. ReCell® is patented, CE‐marked for Europe, TGA‐registered in Australia, and CFDA‐cleared in China. In the United States, ReCell® is an investigational device limited by federal law to investigational use. A pivotal U.S. trial is underway, with patient enrollment completion anticipated by the end of 2015.


Mike Townley
Head of Investment Banking


Email Mike

Dave McDonald
Head of Life Science Investment Banking


Email Dave


Tim Klein

Investment Banking


Email Tim


Rob Martin

Investment Banking


Email Rob


Steve Rickman

Investment Banking


Email Steve